Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2016) 41 EP134A | DOI: 10.1530/endoabs.41.EP134A

1C. Davila University of Medicine and Pharmacy & C.I. Parhon National Institute of Endocrinology, Bucharest, Romania; 2Romanian Association of Psychiatry and Psychotherapy, Bucharest, Romania; 3I.Hatieganu University of Medicine and Pharmacy & Clinical County Hospital, Cluj-Napoca, Romania; 4C.Davila University of Medicine and Pharmacy & University Emergency Hospital, Bucharest, Romania.


Introduction: Depression and associated medication, especially Selective Serotonin Reuptake Inhibitors, may associate high fracture risk through serotonin (but not only). Obesity has been recently proved to be correlated with a higher fracture risk for a few sites as ankle, elbow, shoulder, etc. Moreover, depression and some anti-depressants may increase the calories intake and consecutive increased of Body Mass Index (BMI) is registered.

Aim: We present a fragility fracture medical history in a context of depression and obesity as only obvious causes of osteoporosis.

Material and Methods: The bone profile is analyzed in this case report.

Results: Fifty seven year old non-smoking female patient was diagnosed with multi-nodule goiter at age of 49 and total thyroidectomy was performed. Substitution with daily levothyroxine was continued up to present with consecutive normal TSH levels.

Menstruation stopped at 50 years; she suffered of chronic headache. At age of 53 she was diagnosed with depression and she was offered different types of anti-depressive medication for almost 3 years. At age of 56 she suffered a left elbow fracture and the circumstances of fall indicated an osteoporotic type.

Endocrine check-up was done at that moment. The patient had a BMI of 40 kg/m2; 25-hydroxyvitamin D assay showed an inadequate level of 20.8 ng/ml (N:30–100 ng/ml), with normal bone turnover markers: blood CrossLaps of 0.44 ng/ml (N:0.226–1.008 ng/ml), blood osteocalcin of 25.71 ng/ml (N:15–46 ng/ml), and circulating serotonin of 280 ng/ml (N:80–450 ng/ml). Dual-Energy X-Ray Absorptiometry showed lumbar L1-4 Bone Mineral Density (BMD) of 1.049 g/cm2, T-score=−1.1 S.D., Z-score=−1.4 S.D. Weekly oral risendronat with daily vitamin D/calcium supplements were followed for 1 year: BMD increased to 1.14 g/cm2, T-score=−0.3 S.D., Z-score=−0.5 S.D.

Conclusion: Obesity and depression might associate vitamin D deficiency. Depression and anti-depressants may act on fall risk by attention and gait anomalies. However, both conditions may be not associated relevant BMD changes.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts